本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ionis Pharmaceuticals, Inc

44.84
-2.4100-5.10%
盤後44.840.00000.00%18:08 EDT
成交量:795.64萬
成交額:3.64億
市值:74.52億
市盈率:-12.89
高:47.59
開:47.38
低:44.66
收:47.25
52周最高:86.74
52周最低:44.66
股本:1.66億
流通股本:1.62億
量比:1.89
換手率:4.91%
股息:- -
股息率:- -
每股收益(TTM):-3.4800
每股收益(LYR):-2.3812
淨資產收益率:-105.50%
總資產收益率:-12.42%
市淨率:16.95
市盈率(LYR):-18.83

資料載入中...

2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/18

重要事件披露

8-K - Current report
2020/12/09

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/13

重要事件披露

8-K - Current report
2020/10/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/24

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/31

重要事件披露

8-K - Current report
2020/08/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report